← Back to Search

Outreach mailer for Risk Reduction Behavior

N/A
Waitlist Available
Led By Amir Goren, PhD
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Geisinger patient, Geisinger Health Plan member or Medicaid patient
Chronic illness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Awards & highlights

Study Summary

This trial is testing whether different types of messages on postcards or letters can encourage people with chronic conditions, who haven't seen their doctor in a year, to make an appointment.

Eligible Conditions
  • Risk Reduction Behavior
  • Health Promotion
  • Prevention

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patients - Appointment scheduling
Secondary outcome measures
Patients - Attendance at scheduled appointments within 180 days of mailer
Patients, Members & Medicaid - Attendance at any appointment
Patients, Members & Medicaid - Timing of appointment
Other outcome measures
Patients - Appointment scheduling - Comparing mailers
Patients - Calls to scheduling line

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Physician LetterExperimental Treatment3 Interventions
This group receives a personalized letter signed by a physician with information about why visits are important, and what to expect at the appointment.
Group II: Outreach PostcardExperimental Treatment1 Intervention
This group receives a postcard with a stock image on the front and a message encouraging regular visits to manage health on the back.
Group III: Humorous PostcardExperimental Treatment3 Interventions
This group receives a postcard with with a cartoon image and a visit-related joke on the front and a humorous message on the back, with additional information about why visits are important, and what to expect at the appointment.
Group IV: No-contact ControlActive Control1 Intervention
This group will not receive a study mailer during the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Outreach mailer
2021
N/A
~21570
Humor/Salience
2020
N/A
~63040
Doctor's authority
2021
N/A
~21570
Information
2008
Completed Phase 2
~45710

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
148 Previous Clinical Trials
1,864,531 Total Patients Enrolled
Amir Goren, PhD4.710 ReviewsPrincipal Investigator - Geisinger Clinic
Geisinger Clinic
20 Previous Clinical Trials
510,159 Total Patients Enrolled
5Patient Review
I would highly recommend Dr. Goren. They are extremely professional and the care is great!

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Encouraging Overdue Healthcare Appointment Scheduling Among Patients With Chronic Diseases
Amir Goren 2021. "Encouraging Overdue Healthcare Appointment Scheduling Among Patients With Chronic Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05000619.
~5750 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top